Evidence map›Paper›PMID 41550455›Full record

ArticleACS applied nano materials2025

A Point-of-Care Device for Theophylline Quantification in Human Milk Using Laser-Induced Graphene Electrodes.

Abdulrahman Al-Shami, Mona A Mohamed, Haozheng Ma, Sina Khazaee Nejad, Ali Soleimani, Farbod Amirghasemi, Melissa Banks, Diego Garcia, Alessandro Tasso, Aiman A Yaseen and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS applied nano materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Abdulrahman Al-ShamiAlfred E. Mann Department of Biomedical Engineering, University of Southern California, Los Angeles, California 90089, United States.
Mona A MohamedAlfred E. Mann Department of Biomedical Engineering, University of Southern California, Los Angeles, California 90089, United States.ORCID 0000-0003-2721-5725
Haozheng MaAlfred E. Mann Department of Biomedical Engineering, University of Southern California, Los Angeles, California 90089, United States.
Sina Khazaee NejadAlfred E. Mann Department of Biomedical Engineering, University of Southern California, Los Angeles, California 90089, United States.
Ali SoleimaniAlfred E. Mann Department of Biomedical Engineering, University of Southern California, Los Angeles, California 90089, United States.
Farbod AmirghasemiAlfred E. Mann Department of Biomedical Engineering, University of Southern California, Los Angeles, California 90089, United States.
Melissa BanksAlfred E. Mann Department of Biomedical Engineering, University of Southern California, Los Angeles, California 90089, United States.
Diego GarciaAlfred E. Mann Department of Biomedical Engineering, University of Southern California, Los Angeles, California 90089, United States.
Alessandro TassoAlfred E. Mann Department of Biomedical Engineering, University of Southern California, Los Angeles, California 90089, United States.
Aiman A YaseenSchool of Pharmacy and Pharmaceutical Sciences, Binghamton University, Binghamton, New York 13902, United States.
Maral P S MousaviAlfred E. Mann Department of Biomedical Engineering, University of Southern California, Los Angeles, California 90089, United States; Department of Chemistry, University of Southern California, Los Angeles, California 90089, United States; Department of Pharmacology and Pharmaceutical Sciences, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, California 90089-9121, United States; Department of Psychiatry and the Behavioral Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, United States.ORCID 0000-0003-0004-7178

Funding

Building a two-way communication system: Bio-orthogonal superhydrophobic nanoparticles for controlled stimulation and real-time sensing of neurotransmittersDP2GM150018 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MOUSAVI, MARAL · 2022 to 2025
$2.3M
NIGMS NIH HHS DP2 GM150018
6 · The paper itself

Abstract

Theophylline is commonly used to treat asthma and chronic obstructive pulmonary disease (COPD). It has a narrow therapeutic range (55-110

Indexed as

drug detectionhuman breast milklaser-induced-graphenemilk to plasma ratiopoint-of-caretheophyllinetherapeutic window

Identifiers

PMID41550455
PMCPMC12806177

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.